drugset

drugset / Trial / NCT01419470

Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044

NCT01419470 ↗

Phase 1/2 Completed 24 enrolled Yuhan Corporation

RandomizedParallel-groupTriple-blindBasic science

Summary

safety and tolerability, pharmacokinetics/efficacy of an escalating, repeat doses of YHD1044 in premature ejaculation

Timeline

Start: 2011-02
Primary completion: 2012-05
Completion: 2012-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dapoxetine	Small molecule	—	Oral

Indications